Clinical Trial Update: A Prospective, Randomized TrialComparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate [NA]

View source ↗

Summary

A prospective randomized trial comparing oral N-Acetylcysteine to intravenous sodium bicarbonate in nephropathy was terminated, with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephropathy

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)
• Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: University of Nebraska | Conditions: Nephropathy | NA | Status: TERMINATED | Results posted: 2023-09-21